• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于动态对比增强 MRI 的 Sigmoid 模型分析:鉴别乳腺良恶性肿块及乳腺癌亚型预测。

Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.

机构信息

Department of Radiology, Komaki City Hospital, Komaki, Aichi, Japan.

Division of Health Sciences, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan.

出版信息

J Appl Clin Med Phys. 2022 Jun;23(6):e13651. doi: 10.1002/acm2.13651. Epub 2022 May 20.

DOI:10.1002/acm2.13651
PMID:35594028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9195041/
Abstract

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is performed to distinguish between benign and malignant lesions by evaluating the changes in signal intensity of the acquired image (kinetic curve). This study aimed to verify whether the existing breast DCE-MRI analyzed by the sigmoid model can accurately distinguish between benign and invasive ductal carcinoma (IDC) and predict the subtype. A total of 154 patients who underwent breast MRI for detailed breast mass examinations were included in this study (38 with benign masses and 116 with IDC. The sigmoid model involved the acquisition of images at seven timepoints in 1-min intervals to determine the change in signal intensity before and after contrast injection. From this curve, the magnitude of the increase in signal intensity in the early phase, the time to reach the maximum increase, and the slopes in the early and late phases were calculated. The Mann-Whitney U-test was used for the statistical analysis. The IDC group exhibited a significantly larger and faster signal increase in the early phase and a significantly smaller rate of increase in the late phase than the benign group (P < 0.001). The luminal A-like group demonstrated a significantly longer time to reach the maximum signal increase rate than other IDC subtypes (P < 0.05). The sigmoid model analysis of breast DCE-MRI can distinguish between benign lesions and IDC and may also help in predicting luminal A-like breast cancer.

摘要

动态对比增强磁共振成像(DCE-MRI)通过评估获得的图像信号强度变化(动力学曲线)来区分良恶性病变。本研究旨在验证现有的乳腺 DCE-MRI 分析的 Sigmoid 模型是否可以准确区分良性和浸润性导管癌(IDC)并预测亚型。共有 154 名接受乳腺 MRI 详细乳腺肿块检查的患者纳入本研究(38 名良性肿块患者和 116 名 IDC 患者)。Sigmoid 模型涉及在 1 分钟间隔内采集 7 个时间点的图像,以确定对比剂注射前后的信号强度变化。从该曲线中计算出早期信号强度增加的幅度、达到最大增加的时间以及早期和晚期的斜率。采用 Mann-Whitney U 检验进行统计学分析。IDC 组在早期阶段的信号增加幅度明显更大、更快,而在晚期阶段的增加率明显更小,与良性组相比差异有统计学意义(P < 0.001)。腔A型样组达到最大信号增加率的时间明显长于其他 IDC 亚型(P < 0.05)。乳腺 DCE-MRI 的 Sigmoid 模型分析可以区分良性病变和 IDC,并且可能有助于预测腔A型乳腺癌。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/bef8ce31f1e8/ACM2-23-e13651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/cd723cd33f26/ACM2-23-e13651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/25cb11425e41/ACM2-23-e13651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/f923e3682bf8/ACM2-23-e13651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/d6c7f14157e2/ACM2-23-e13651-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/3a87acb145d5/ACM2-23-e13651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/bef8ce31f1e8/ACM2-23-e13651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/cd723cd33f26/ACM2-23-e13651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/25cb11425e41/ACM2-23-e13651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/f923e3682bf8/ACM2-23-e13651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/d6c7f14157e2/ACM2-23-e13651-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/3a87acb145d5/ACM2-23-e13651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c14/9195041/bef8ce31f1e8/ACM2-23-e13651-g002.jpg

相似文献

1
Sigmoid model analysis of breast dynamic contrast-enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction.基于动态对比增强 MRI 的 Sigmoid 模型分析:鉴别乳腺良恶性肿块及乳腺癌亚型预测。
J Appl Clin Med Phys. 2022 Jun;23(6):e13651. doi: 10.1002/acm2.13651. Epub 2022 May 20.
2
Differentiation between subcentimeter carcinomas and benign lesions using kinetic parameters derived from ultrafast dynamic contrast-enhanced breast MRI.利用超快动态对比增强乳腺 MRI 获得的动力学参数区分亚厘米大小的癌与良性病变。
Eur Radiol. 2020 Feb;30(2):756-766. doi: 10.1007/s00330-019-06392-5. Epub 2019 Aug 29.
3
Enhanced Masses on Contrast-Enhanced Breast: Differentiation Using a Combination of Dynamic Contrast-Enhanced MRI and Quantitative Evaluation with Synthetic MRI.对比增强乳腺成像中的强化肿块:联合动态对比增强磁共振成像与合成磁共振成像定量评估进行鉴别诊断
J Magn Reson Imaging. 2021 Feb;53(2):381-391. doi: 10.1002/jmri.27362. Epub 2020 Sep 11.
4
Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.体素内不相干运动扩散加权成像作为动态对比增强磁共振成像的辅助手段,以提高乳腺良恶性病变鉴别诊断的准确性。
Magn Reson Imaging. 2017 Feb;36:175-179. doi: 10.1016/j.mri.2016.10.005. Epub 2016 Oct 11.
5
Model-Free and Model-based Parameters Derived From CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI: Associations With Prognostic Factors and Molecular Subtypes of Invasive Ductal Breast Cancer.无模型和基于模型的参数源自 CAIPIRINHA-Dixon-TWIST-VIBE DCE-MRI:与浸润性导管乳腺癌的预后因素和分子亚型的关联。
J Magn Reson Imaging. 2023 Jul;58(1):81-92. doi: 10.1002/jmri.28533. Epub 2022 Nov 26.
6
Computer-Aided Diagnosis Scheme for Distinguishing Between Benign and Malignant Masses in Breast DCE-MRI.用于鉴别乳腺动态对比增强磁共振成像中良性与恶性肿块的计算机辅助诊断方案
J Digit Imaging. 2016 Jun;29(3):388-93. doi: 10.1007/s10278-015-9856-7.
7
Kinetic curves of malignant lesions are not consistent across MRI systems: need for improved standardization of breast dynamic contrast-enhanced MRI acquisition.恶性病变的动力学曲线在不同的MRI系统中并不一致:需要改进乳腺动态对比增强MRI采集的标准化。
AJR Am J Roentgenol. 2009 Sep;193(3):832-9. doi: 10.2214/AJR.08.2025.
8
Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.超快速动态对比增强乳腺 MRI 可能生成乳腺癌的预后成像标志物。
Breast Cancer Res. 2020 May 28;22(1):58. doi: 10.1186/s13058-020-01292-9.
9
The additional utility of ultrafast MRI on conventional DCE-MRI in evaluating preoperative MRI of breast cancer patients.超快速 MRI 在常规 DCE-MRI 术前评估乳腺癌患者中的附加作用。
Eur J Radiol. 2020 Mar;124:108841. doi: 10.1016/j.ejrad.2020.108841. Epub 2020 Jan 17.
10
Cancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.动态对比增强磁共振图像上的癌性乳腺病变:基于图像的预后标志物的计算机特征化。
Radiology. 2010 Mar;254(3):680-90. doi: 10.1148/radiol.09090838. Epub 2010 Feb 1.

引用本文的文献

1
A simplified method for generating maximum slope maps in ultrafast dynamic contrast-enhanced breast magnetic resonance imaging.一种在超快动态对比增强乳腺磁共振成像中生成最大斜率图的简化方法。
Radiol Phys Technol. 2025 Jul 1. doi: 10.1007/s12194-025-00931-0.

本文引用的文献

1
New parameters of ultrafast dynamic contrast-enhanced breast MRI using compressed sensing.使用压缩感知的超快动态对比增强乳腺MRI的新参数
J Magn Reson Imaging. 2020 Jan;51(1):164-174. doi: 10.1002/jmri.26838. Epub 2019 Jun 18.
2
Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.基于直方图和纹理特征的术前动态对比增强磁共振成像的药代动力学定量参数对乳腺癌 Luminal A 和 B 分子亚型的鉴别。
Acad Radiol. 2020 Mar;27(3):e35-e44. doi: 10.1016/j.acra.2019.05.002.
3
[Comparison of Kinetic Curve between Gadodiamide Hydrate and Gadobutrol on Breast Dynamic Contrast-enhanced Magnetic Resonance Imaging in Invasive Ductal Carcinoma].
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2018;74(11):1313-1318. doi: 10.6009/jjrt.2018_JSRT_74.11.1313.
4
Diagnostic value of electric properties tomography (EPT) for differentiating benign from malignant breast lesions: comparison with standard dynamic contrast-enhanced MRI.电阻抗断层成像(EPT)在鉴别良恶性乳腺病变中的诊断价值:与标准动态对比增强 MRI 的比较。
Eur Radiol. 2019 Apr;29(4):1778-1786. doi: 10.1007/s00330-018-5708-4. Epub 2018 Sep 25.
5
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.功能成像与免疫组化标志物与乳腺癌亚型预测的关系:一项 PET/MRI 研究。
Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1680-1693. doi: 10.1007/s00259-018-4010-7. Epub 2018 Apr 25.
6
Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the International Breast MR Consortium 6883 trial.鉴别乳腺良性和恶性肿瘤:使用来自国际乳腺磁共振成像联盟6883试验的多机构动态对比增强磁共振成像数据对动力学建模方法进行初步比较
J Med Imaging (Bellingham). 2018 Jan;5(1):011019. doi: 10.1117/1.JMI.5.1.011019. Epub 2018 Jan 22.
7
Differentiation between malignant and benign breast masses: combination of semi-quantitative analysis on DCE-MRI and histogram analysis of ADC maps.乳腺良恶性肿块的鉴别:动态对比增强磁共振成像(DCE-MRI)的半定量分析与表观扩散系数(ADC)图的直方图分析相结合
Clin Radiol. 2018 May;73(5):460-466. doi: 10.1016/j.crad.2017.11.026. Epub 2017 Dec 30.
8
Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions.体素内不相干运动和定量非高斯扩散磁共振成像:评估几种良恶性乳腺病变标志物的诊断和预后价值。
Radiology. 2018 May;287(2):432-441. doi: 10.1148/radiol.2017162853. Epub 2017 Nov 2.
9
Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.利用体素内不相干运动和动态对比增强磁共振成像鉴别腔面A型和腔面B型乳腺癌
Acad Radiol. 2017 Dec;24(12):1575-1581. doi: 10.1016/j.acra.2017.06.016. Epub 2017 Aug 1.
10
A one-step biomarker quantification methodology for DCE-MRI of adnexal masses: Capturing kinetic pattern from early to late enhancement.附件肿块的 DCE-MRI 的一步式生物标志物定量方法:从早期到晚期增强捕获动力学模式。
Magn Reson Med. 2018 Feb;79(2):1165-1171. doi: 10.1002/mrm.26743. Epub 2017 May 7.